Compare Norfolk Southern Corporation (NSC) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Norfolk Southern Corporation vs TransMedics Group Inc — how do they compare? Norfolk Southern Corporation trades at $333.48 (market cap $75.23B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Norfolk Southern Corporation is far larger — about 29.6× TransMedics Group Inc's market cap, and Norfolk Southern Corporation pays a 1.61% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| NSC | TMDX | |
|---|---|---|
Market Cap | $75.23B | $2.54B |
Sector | Technology | Technology |
52-Week High | $340.16 | $150.42 |
52-Week Low | $272.35 | $61.99 |
Enterprise Value | $90.99B | $2.94B |
Dividend Yield | 1.61% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Norfolk Southern Corporation
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
